Table 2.
Hours/day | Men (n = 79,033) | Women (n = 93,469) | P for heterogeneityd |
||||||
---|---|---|---|---|---|---|---|---|---|
Cases | HR (95% CI)a | Casesb | HR (95% CI)c | Cases | HR (95% CI)a | Casesb | HR (95% CI)c | ||
Sleep | |||||||||
≤5 | 205 | 1.00 (ref) | 190 | 1.00 (ref) | 226 | 1.00 (ref) | 190 | 1.00 (ref) | |
6 | 549 | 0.89 (0.76–1.05) | 528 | 0.93 (0.78–1.09) | 556 | 1.06 (0.91–1.24) | 525 | 1.17 (0.99–1.39) | |
7 | 713 | 0.89 (0.76–1.04) | 679 | 0.91 (0.77–1.07) | 608 | 0.91 (0.78–1.07) | 562 | 1.00 (0.85–1.18) | |
8 | 629 | 0.96 (0.82–1.13) | 591 | 0.97 (0.82–1.14) | 505 | 0.98 (0.84–1.15) | 469 | 1.07 (0.90–1.27) | |
≥9 | 245 | 1.01 (0.84–1.22) | 237 | 1.01 (0.83–1.22) | 194 | 1.11 (0.91–1.34) | 181 | 1.20 (0.98–1.47) | |
P for trend | 0.31 | 0.54 | 0.93 | 0.67 | 0.78 | ||||
Total sitting | |||||||||
<5 | 493 | 1.00 (ref) | 463 | 1.00 (ref) | 420 | 1.00 (ref) | 377 | 1.00 (ref) | |
5‒<7 | 508 | 0.95 (0.84–1.08) | 483 | 0.93 (0.82–1.06) | 437 | 0.99 (0.87–1.14) | 402 | 0.98 (0.85–1.12) | |
7‒<9 | 478 | 0.95 (0.84–1.08) | 456 | 0.92 (0.81–1.05) | 435 | 1.03 (0.90–1.18) | 405 | 1.00 (0.87–1.16) | |
9‒≤11 | 434 | 1.04 (0.91–1.18) | 412 | 1.00 (0.87–1.14) | 395 | 1.07 (0.93–1.23) | 360 | 1.01 (0.87–1.17) | |
>11 | 428 | 1.00 (0.87–1.14) | 411 | 0.96 (0.84–1.10) | 402 | 0.96 (0.83–1.10) | 383 | 0.92 (0.80–1.07) | |
P for trend | 0.60 | 0.95 | 0.84 | 0.39 | 0.71 | ||||
Sitting watching TV | |||||||||
<1 | 262 | 1.00 (ref) | 252 | 1.00 (ref) | 245 | 1.00 (ref) | 226 | 1.00 (ref) | |
1‒<3 | 883 | 1.05 (0.92–1.21) | 838 | 1.01 (0.88–1.16) | 749 | 1.02 (0.89–1.18) | 687 | 0.98 (0.84–1.14) | |
3‒<5 | 902 | 1.08 (0.94–1.24) | 864 | 0.99 (0.86–1.14) | 823 | 1.14 (0.99–1.32) | 765 | 1.04 (0.90–1.21) | |
≥5 | 256 | 1.16 (0.98–1.38) | 238 | 0.98 (0.82–1.18) | 231 | 1.19 (0.99–1.43) | 213 | 1.02 (0.84–1.24) | |
P for trend | 0.10 | 0.72 | 0.006 | 0.3634 | 0.42 | ||||
Moderate activity | |||||||||
<0.14 | 699 | 1.00 (ref) | 654 | 1.00 (ref) | 441 | 1.00 (ref) | 391 | 1.00 (ref) | |
0.14‒<0.43 | 613 | 0.88 (0.79–0.98) | 584 | 0.90 (0.80–1.00) | 614 | 0.95 (0.84–1.08) | 565 | 0.97 (0.86–1.11) | |
0.43‒<0.86 | 469 | 0.87 (0.77–0.98) | 445 | 0.88 (0.78–1.00) | 456 | 0.91 (0.80–1.04) | 425 | 0.95 (0.83–1.09) | |
0.86‒<1.43 | 257 | 0.83 (0.72–0.96) | 246 | 0.84 (0.73–0.98) | 250 | 0.86 (0.74–1.01) | 241 | 0.92 (0.78–1.09) | |
≥1.43 | 303 | 0.81 (0.70–0.93) | 296 | 0.83 (0.72–0.95) | 328 | 0.91 (0.78–1.05) | 305 | 0.94 (0.80–1.09) | |
P for trend | 0.004 | 0.01 | 0.24 | 0.41 | 0.25 | ||||
Vigorous work | |||||||||
0 | 1120 | 1.00 (ref) | 1059 | 1.00 (ref) | 1614 | 1.00 (ref) | 1495 | 1.00 (ref) | |
>0‒<0.14 | 548 | 0.91 (0.82–1.01) | 518 | 0.91 (0.82–1.01) | 277 | 1.03 (0.90–1.17) | 254 | 1.03 (0.90–1.18) | |
0.14‒<0.43 | 271 | 0.81 (0.71–0.93) | 255 | 0.82 (0.72–0.94) | 81 | 0.81 (0.65–1.02) | 76 | 0.84 (0.66–1.05) | |
≥0.43 | 371 | 0.92 (0.82–1.04) | 364 | 0.94 (0.83–1.06) | 72 | 1.00 (0.79–1.27) | 65 | 1.01 (0.79–1.30) | |
P for trend | 0.26 | 0.42 | 0.75 | 0.86 | 0.96 | ||||
Strenuous sports | |||||||||
0 | 1512 | 1.00 (ref) | 1438 | 1.00 (ref) | 1533 | 1.00 (ref) | 1413 | 1.00 (ref) | |
>0‒<0.14 | 419 | 0.91 (0.82–1.02) | 399 | 0.97 (0.87–1.08) | 276 | 0.90 (0.79–1.03) | 255 | 0.96 (0.84–1.10) | |
0.14‒<0.43 | 194 | 0.78 (0.67–0.90) | 184 | 0.85 (0.73–1.00) | 151 | 0.96 (0.82–1.14) | 139 | 1.05 (0.88–1.25) | |
≥0.43 | 192 | 0.79 (0.68–0.92) | 184 | 0.89 (0.76–1.04) | 106 | 0.93 (0.76–1.14) | 99 | 1.05 (0.85–1.29) | |
P for trend | <0.001 | 0.05 | 0.39 | 0.56 | 0.07 | ||||
Vigorous activity | |||||||||
0 | 882 | 1.00 (ref) | 828 | 1.00 (ref) | 1300 | 1.00 (ref) | 1198 | 1.00 (ref) | |
>0‒<0.21 | 407 | 0.93 (0.82–1.04) | 384 | 0.94 (0.83–1.06) | 366 | 1.07 (0.96–1.21) | 342 | 1.12 (0.99–1.27) | |
0.21‒<0.46 | 391 | 0.91 (0.80–1.02) | 378 | 0.96 (0.85–1.09) | 197 | 0.86 (0.74–1.00) | 176 | 0.88 (0.75–1.03) | |
0.46‒<0.71 | 287 | 0.82 (0.71–0.94) | 272 | 0.86 (0.75–0.99) | 128 | 0.94 (0.78–1.13) | 121 | 1.02 (0.84–1.23) | |
≥0.71 | 374 | 0.80 (0.70–0.90) | 363 | 0.86 (0.75–0.97) | 98 | 0.92 (0.75–1.13) | 90 | 1.01 (0.81–1.26) | |
P for trend | <0.001 | 0.02 | 0.19 | 0.83 | 0.32 | ||||
Moderate/vigorous activity | |||||||||
0‒<0.32 | 516 | 1.00 (ref) | 481 | 1.00 (ref) | 402 | 1.00 (ref) | 359 | 1.00 (ref) | |
0.32‒<0.71 | 456 | 0.92 (0.81–1.04) | 430 | 0.92 (0.81–1.05) | 543 | 0.99 (0.87–1.12) | 498 | 0.99 (0.87–1.14) | |
0.71‒<1.07 | 419 | 0.83 (0.73–0.94) | 393 | 0.84 (0.73–0.96) | 434 | 0.93 (0.81–1.06) | 398 | 0.95 (0.82–1.09) | |
1.07‒<1.79 | 455 | 0.76 (0.67–0.86) | 440 | 0.80 (0.70–0.92) | 325 | 0.82 (0.71–0.95) | 313 | 0.89 (0.76–1.04) | |
≥1.79 | 495 | 0.77 (0.68–0.87) | 481 | 0.80 (0.70–0.91) | 385 | 0.91 (0.79–1.05) | 359 | 0.95 (0.82–1.11) | |
P for trend | <0.001 | 0.003 | 0.15 | 0.45 | 0.25 | ||||
Moderate/vigorous activity (MET-hours) |
|||||||||
<1.42 | 454 | 1.00 (ref) | 423 | 1.00 (ref) | 394 | 1.00 (ref) | 353 | 1.00 (ref) | |
1.42‒<2.86 | 401 | 0.95 (0.83–1.09) | 379 | 0.96 (0.83–1.10) | 503 | 0.94 (0.83–1.08) | 461 | 0.95 (0.82–1.09) | |
2.86‒<4.86 | 485 | 0.83 (0.73–0.95) | 454 | 0.85 (0.74–0.97) | 476 | 0.92 (0.81–1.06) | 436 | 0.94 (0.82–1.08) | |
4.86‒<9.14 | 537 | 0.82 (0.72–0.93) | 519 | 0.86 (0.76–0.98) | 419 | 0.81 (0.71–0.93) | 403 | 0.87 (0.75–1.00) | |
≥9.14 | 464 | 0.72 (0.63–0.82) | 450 | 0.76 (0.66–0.87) | 297 | 0.90 (0.78–1.05) | 274 | 0.94 (0.80–1.11) | |
P for trend | <0.001 | <0.001 | 0.17 | 0.53 | 0.07 | ||||
Total METs | |||||||||
<1.38 | 416 | 1.00 (ref) | 394 | 1.00 (ref) | 410 | 1.00 (ref) | 384 | 1.00 (ref) | |
1.38‒<1.55 | 446 | 0.87 (0.76–1.00) | 426 | 0.91 (0.79–1.04) | 427 | 1.04 (0.91–1.20) | 396 | 1.07 (0.93–1.23) | |
1.55‒<1.68 | 493 | 0.90 (0.79–1.03) | 465 | 0.94 (0.82–1.08) | 461 | 1.05 (0.92–1.20) | 433 | 1.11 (0.97–1.28) | |
1.68‒<1.83 | 469 | 0.82 (0.72–0.94) | 445 | 0.87 (0.76–1.00) | 449 | 1.01 (0.88–1.16) | 412 | 1.07 (0.92–1.23) | |
≥1.83 | 517 | 0.81 (0.71–0.93) | 495 | 0.88 (0.77–1.00) | 342 | 0.99 (0.86–1.15) | 302 | 1.03 (0.89–1.21) | |
P for trend | 0.001 | 0.05 | 0.80 | 0.61 | 0.13 |
Abbreviation: MET, metabolic equivalent.
Adjusted by Cox proportional hazards regression for age at cohort entry and race/ethnicity.
Excluding participants with missing information on covariates.
Further adjusted for family history of colorectal cancer, history of colorectal polyp, body mass index, pack-years of cigarette smoking, multivitamin use, non-steroidal anti-inflammatory drug use, menopausal hormone therapy use for women only, and intake of alcohol, total energy, red meat, dietary fiber, calcium, folate, and vitamin D.
Tests for heterogeneity between men and women were performed based on the multivariate-adjusted models.